The former headquarters of Merck Serono in Geneva (which now hosts the Campus Biotech).
Merck Serono (EMD Serono in the United States and Canada) is a pharmaceutical company headquartered in Darmstadt, Germany, and a brand and division of Merck focused on biopharmaceuticals.[1]
In September 2006, Merck KGaA announced its intent to purchase the majority of Serono shares from Ernesto Bertarelli and the Bertarelli family. The Merck-Serono merger was announced on 21 September 2006. Merck KGaA and Serono operated as distinct entities until at least January 2007. As of January 5, 2007, Merck held the majority shares of Serono. The new company is called Merck Serono international SA. In 2012, Merck Serono moved its headquarters from Geneva, Switzerland to Darmstadt.
Drugs they market include Erbitux, UFT, Rebif, Mavenclad, Novantrone, Gonal, Ovidrel/Ovitrelle, Zorbtive, Luveris, Saizen, Serostim, Glucophage, Concor and Euthyrox. Raptiva was withdrawn in 2007.
In the U.S. and Canada, Merck Serono is known as EMD Serono, as the former Merck subsidiary Merck & Co. holds the rights to the name Merck in those countries.
MerckSerono (EMD Serono in the United States and Canada) is a pharmaceutical company headquartered in Darmstadt, Germany, and a brand and division of...
Serono was a biotechnology company headquartered in Geneva, Switzerland. It was acquired by the German pharmaceutical company Merck in 2006. The company...
historical predecessors: Merck Group MilliporeSigma Merck Millipore MerckSeronoMerck (Founded 1668 by Jacob Friedrich Merck) Serono (Acq 2006) Millipore...
including: the Merck Group, a German chemical, pharmaceutical and life sciences company founded in 1668 MerckSerono (known as EMD Serono in the United...
family sold the company to Merck KGaA of Germany in January 2007 for US$13.3 billion, forming the new company Merck-Serono. His family split an estimated...
"Les sciences de la vie recrutent à Genève grâce à des ex-employés de MerckSerono", Le Temps, Tuesday 21 April 2015, page 13. (in French) Health Valley...
Massachusetts - in a class-action lawsuit that involved MerckSerono and Serostim - fined Serono a total of $704 million in criminal and civil liabilities...
2018-01-07. "Compugen, MerckSerono set up biomarkers JV". Globes. 25 June 2012. Retrieved 2018-01-07. "Metabomed, ChanBio join MerckSerono Israel Bioincubator"...
Seattle-based biotech company, ZymoGenetics, which handed the product over to MerckSerono for further development. Hartung HP, Kieseier BC (July 2010). "Atacicept:...
former MerckSerono building, in Geneva (Switzerland). The Campus Biotech is a part of the Swiss Innovation Park. End of June 2013, MerckSerono left its...
improve lives. The Center is based at Campus Biotech (in the former MerckSerono building) located in Geneva, Switzerland. The CEO of the Wyss Center...
created in November 2000 as a spin-off of Serono, a Swiss-based biotechnology company, now part of Merck-Serono, by private founders. Its aim was to provide...
whole is coming from healthcare. The new venture fund recently opened by MerckSerono and the fund just closed by Ascension Health Ventures are just a few...
Humatrope (Lilly), Genotropin (Pfizer), Norditropin (Novo), and Saizen (MerckSerono). In 2006, the U.S. Food and Drug Administration (FDA) approved a version...
Wistar Institute in Philadelphia, Pennsylvania Produced and developed by MerckSerono in cooperation with Takeda Pharmaceutical, it has undergone phase II...
(Pfizer), Norditropin (Novo Nordisk), Tev-Tropin (Teva) and Saizen (MerckSerono). The products are nearly identical in composition, efficacy, and cost...
hormone, a.k.a. GH) used for growth hormone treatment. Manufactured by MerckSerono, Saizen is produced by recombinant DNA technology from a mammalian cell...
Efalizumab (brand name Raptiva, Genentech, MerckSerono) is a formerly available medication designed to treat autoimmune diseases, originally marketed...
Genset Health care Biotechnology Paris 1989 Defunct 2002, now part of MerckSerono (Germany) Getlink Industrials Transportation services Paris 1986 Infrastructure...
assess. Merck rates this as a medium risk." Merck KGaA further reported with respect to its pharma division, MerckSerono: "Over 80% of the MerckSerono senior...
sold to Merck KGaA in 2006. In 2007, a Phase III clinical trial was started, scheduled to run until 2011. In October 2011 Merck, now Merck-Serono, announced...
and pilot production in the life science sector. Companies such as MerckSerono and Bracco chose the Park as the location for their research and development...
Puerto Rico Plant". justice.gov. 26 October 2010. Retrieved 25 August 2012. "Serono to Pay $704 Million for the Illegal Marketing of AIDS Drug". justice.gov...
drugs of 2013; May 29, 2014 Bristol-Myers Squibb Company 2013 Form 10-K MerckSerono Investor & Analyst Day 2014 – Belen Garijo's presentation – Slide 41...
Amgen vs. TKT Aventis in 2000, Amgen vs. Roche in 2009, and Biogen vs. Merck - Serono in 2018; he was on the winning side in all. In 1963 he married Pamela...
pharmaceutical companies AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, MerckSerono, Janssen Pharmaceutica, and Pfizer. The purpose of the collaboration...
Global Information